Zpráva o průběhu klinického hodnocení KDO_DC1311 Annual Report za období 10. září 2020 ‒ 9. září 2021
Title in English | KDO_DC1311 Clinical trial Annual Report for the period September 10, 2020 - September 9, 2021 |
---|---|
Authors | |
Year of publication | 2021 |
MU Faculty or unit | |
Web | KDO_DC1311 |
Description | Combination antitumor therapy with ex vivo manipulated interleukin-12-producing dendritic cells in pediatric, adolescent, and young adult patients with high-risk progressive, relapsed, or primarily metastatic malignancies, protocol number KDO_DC1311. |
Related projects: |